Generated by OntoTerm. Updated: 28/08/2002 3:23:28

ALLOGENEIC-BONE-MARROW-TRANSPLANT


origination date: 07/07/2000
originator: Pamela
subject field: medicine: treatment
check date: 12/08/2001
checker: Pamela
URL: http://www.cancercenter.com/home/2/39/40/42/

originator: Arianne
origination date: 11/01/2001
URL:
http://www.intouchlive.com/journals/oncology/o9903sup1ee.htm

originator: Arianne
origination date: 11/01/2001
URL:
http://www.buenasalud.com/lib/ShowDoc.cfm?LibDocID=2852&ReturnCatID=102

originator: Arianne
origination date: 11/01/2001

Conceptual Structures
ISABONE-MARROW-TRANSPLANTATION
ANCESTORSALL
BONE-MARROW-TRANSPLANTATION
CANCER-MEDICAL-SERVE
CANCER-TREATMENT
EVENT
HEALTH-SERVE
HEMATOPOIETIC-TREATMENT
MEDICAL-SERVE
PROFESSIONAL-SERVICE-EVENT
SERVICE-EVENT
SOCIAL-EVENT
SURGERY
SURGERY-BY-BODY-PART-AFFECTED
SURGERY-BY-BODY-PART-REMOVED
TRANSPLANTATION
TREATMENT-BY-BODY-PART-AFFECTED
TREATMENT-TO-ATTACK-CANCER
WORK-ACTIVITY


English
allogenic bone marrow transplantterm type: main entry term
part of speech: noun
number: singular
reliability code: 10
definition: bone marrow transplant in which the patient receives bone marrow from a compatible, though not genetically identical donor. Closeness of match (and lower risk of rejection) depends on human leukocyte antigens, six markers in white blood cells. (en)
context (x): Albmtra.txt

origination date: 29/10/2001
originator: Arianne

Spanish
trasplante alogénico de médula óseaterm type: main entry term
part of speech: noun
gender: masculine
number: singular
reliability code: 10
definition: trasplante de médula ósea en que el paciente recibe médula ósea de un donante compatible, pero no genéticamente idéntico. Los marcadores utilizados para juzgar la compatibilidad son los antígenos leucocitarios humanos. (es)
context (x): Trasalo.txt

origination date: 29/10/2001
originator: Arianne
trasplante homólogo de médula óseaterm type: synonym
part of speech: noun
gender: masculine
number: singular
reliability code: 7
definition: trasplante de médula ósea en que el paciente recibe médula ósea de un donante compatible, pero no genéticamente idéntico. Los marcadores utilizados para juzgar la compatibilidad son los antígenos leucocitarios humanos. (es)